Literature DB >> 24914877

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: review and update.

Pallavi P Patwari1, Lisa F Wolfe.   

Abstract

PURPOSE OF REVIEW: The focus of this review is to compare and contrast two orphan disorders of late-onset hypoventilation. Specifically, rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) and congenital central hypoventilation syndrome (CCHS) are distinct in presentation, pathophysiology, and etiology. RECENT
FINDINGS: While limited new information is available, appreciation and understanding of rare disorders can be attained through case reports. Recent literature in ROHHAD has included case reports with new findings that may provide insight into pathophysiology involving possible aberrant immune process and dysregulation at the level of the orexinergic system.
SUMMARY: The etiology of ROHHAD continues to be elusive. The hope is that, with growing recognition, discussion, and investigation into the overlap of ROHHAD with disorders outside congenital central hypoventilation syndrome, further advancement will be made.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24914877     DOI: 10.1097/MOP.0000000000000118

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  14 in total

1.  Images: Sleep-disordered breathing and hypoventilation in a child with obesity and hypothalamic dysfunction.

Authors:  Radhika Ghosh; Manisha Malik; Tanicia C Daley; Ajay S Kasi
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

2.  Peri-operative management of a child with ROHHAD-NET syndrome undergoing neural crest tumour excision.

Authors:  S Puri; S Yaddanapudi; P Menon
Journal:  Anaesth Rep       Date:  2022-06-17

Review 3.  Autoimmunity Related to Adipsic Hypernatremia and ROHHAD Syndrome.

Authors:  Akari Nakamura-Utsunomiya
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

4.  Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose Cyclophosphamide.

Authors:  Lisa A Jacobson; Shruti Rane; Lisa J McReynolds; Diana A Steppan; Allen R Chen; Ido Paz-Priel
Journal:  Pediatrics       Date:  2016-06-16       Impact factor: 7.124

5.  Chewing gum: alternative therapy to oxygen intolerance.

Authors:  Kanokkarn Sunkonkit; Sarah Selvadurai; E Ann Yeh; Jill Hamilton; Indra Narang
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

6.  Rapid-onset obesity, hypoventilation, hypothalamic dysfunction, autonomic dysregulation and neuroendocrine tumor syndrome with a homogenous enlargement of the pituitary gland: a case report.

Authors:  Lama Aljabban; Lina Kassab; Nour Alhuda Bakoura; Mohammad Fayez Alsalka; Ismaeil Maksoud
Journal:  J Med Case Rep       Date:  2016-11-22

7.  Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHADNET) Syndrome: A Systematic Review.

Authors:  Jiwon M Lee; Jaewon Shin; Sol Kim; Heon Yung Gee; Joon Suk Lee; Do Hyeon Cha; John Hoon Rim; Se-Jin Park; Ji Hong Kim; Ahmet Uçar; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Biomed Res Int       Date:  2018-11-21       Impact factor: 3.411

8.  ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison.

Authors:  Sarah F Barclay; Casey M Rand; Lisa Nguyen; Richard J A Wilson; Rachel Wevrick; William T Gibson; N Torben Bech-Hansen; Debra E Weese-Mayer
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

Review 9.  TECPR2 mutation-associated respiratory dysregulation: more than central apnea.

Authors:  Pallavi P Patwari; Lisa F Wolfe; Girish D Sharma; Elizabeth Berry-Kravis
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

10.  Psychiatric Symptoms in Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome and its Treatment: A Case Report.

Authors:  Habib Erensoy; Mehmet Emin Ceylan; Alper Evrensel
Journal:  Chin Med J (Engl)       Date:  2016-01-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.